MNPR
Monopar Therapeutics Inc
NASDAQ: MNPR · HEALTHCARE · BIOTECHNOLOGY
$52.15
+4.05% today
Updated 2026-04-30
Market cap
$361.51M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.85
Dividend yield
—
52W range
$28 – $105
Volume
0.2M
Monopar Therapeutics Inc (MNPR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $122400.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | -100.0% | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | $122400.00 | — | — | — | — | — |
| Gross margin | — | — | — | — | — | 100.0% | — | — | — | — | — |
| R&D | $101487.00 | $280355.00 | $15.44M | $1.77M | $1.97M | $4.07M | $6.49M | $7.59M | $5.60M | $13.01M | $9.90B |
| SG&A | $587075.00 | $912474.00 | $1.17M | $1.63M | $2.36M | $2.44M | $2.63M | $2.95M | $3.23M | $3.16M | $6.80B |
| Operating income | $-689000.00 | $-1.19M | $-16.60M | $-3.40M | $-4.32M | $-6.51M | $-9.13M | $-10.54M | $-8.83M | $-16.16M | $-16.70M |
| Operating margin | — | — | — | — | — | -5317.7% | — | — | — | — | — |
| EBITDA | $1251.00 | $-1.19M | $-16.60M | $-3.20M | $-4.32M | $-6.30M | $-9.08M | $-10.52M | $-8.83M | $-16.16M | $-16.70M |
| EBITDA margin | — | — | — | — | — | -5150.8% | — | — | — | — | — |
| EBIT | $-687311.00 | $-1.19M | $-16.60M | $-3.40M | $-4.32M | $-13.14M | $-9.13M | $-10.54M | $-8.40M | $-31.75M | — |
| Interest expense | $0.00 | $7232.00 | $48255.00 | $103215.00 | $98887.00 | $81902.00 | $24024.00 | $21239.00 | — | — | — |
| Income tax | $-689000.00 | $800.00 | $-2.10M | $-71615.00 | $-98887.00 | $-81902.00 | $-24024.00 | $-21239.00 | $-8831.00 | — | — |
| Effective tax rate | 50.1% | -0.1% | 11.3% | 2.2% | 2.3% | 1.3% | 0.3% | 0.2% | 0.1% | 0.0% | 0.0% |
| Net income | $-687000.00 | $-1.19M | $-16.55M | $-3.23M | $-4.13M | $-6.30M | $-9.08M | $-10.49M | $-8.40M | $-15.59M | $-13.72M |
| Net income growth (YoY) | — | -72.6% | -1296.3% | +80.5% | -27.8% | -52.8% | -44.0% | -15.6% | +19.9% | -85.5% | +12.0% |
| Profit margin | — | — | — | — | — | -5150.8% | — | — | — | — | — |